Patent ID: 7670591
Filing Date: 2010-03-02
Classification: A61P,C07D

Abstract:
1. A compound or a pharmaceutically acceptable salt thereof, wherein: the compound corresponds to Formula Ia: R1 is selected from the group consisting of hydrogen, halo, C R2 is selected from the group consisting of hydrogen, fluoro, bromo, iodo, C Q is a pyrimidine ring: R3 is selected from the group consisting of fluoro, bromo, iodo, C G1 is: X G2 is phenyl optionally substituted with a substituent selected from the group consisting of fluoro, bromo, iodo, methyl, and methoxy; and one or more of the atoms of formula Ia is/are optionally a detectable isotope; with the following provisos: 5-(6-methyl-1,3-benzoxazol-2-yl)pyrimidin-2-amine, or 5-(6-methoxy-1,3-benzoxazol-2-yl)-N-phenylpyrimidin-2-amine.